These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27373757)

  • 1. RETRACTED: Evaluation of behavioral problems after prenatal dexamethasone treatment in Swedish adolescents at risk of CAH.
    Wallensteen L; Zimmermann M; Sandberg MT; Gezelius A; Nordenström A; Hirvikoski T; Lajic S
    Horm Behav; 2016 Sep; 85():5-11. PubMed ID: 27373757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of behavioral problems after prenatal dexamethasone treatment in Swedish children and adolescents at risk of congenital adrenal hyperplasia.
    Wallensteen L; Karlsson L; Messina V; Gezelius A; Sandberg MT; Nordenström A; Hirvikoski T; Lajic S
    Horm Behav; 2018 Feb; 98():219-224. PubMed ID: 29410007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone.
    Hirvikoski T; Nordenström A; Lindholm T; Lindblad F; Ritzén EM; Wedell A; Lajic S
    J Clin Endocrinol Metab; 2007 Feb; 92(2):542-8. PubMed ID: 17148562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of prenatally treated children at risk for congenital adrenal hyperplasia: does dexamethasone cause behavioural problems?
    Hirvikoski T; Nordenström A; Lindholm T; Lindblad F; Ritzén EM; Lajic S
    Eur J Endocrinol; 2008 Sep; 159(3):309-16. PubMed ID: 18579553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: the Swedish experience and standpoint.
    Hirvikoski T; Nordenström A; Wedell A; Ritzén M; Lajic S
    J Clin Endocrinol Metab; 2012 Jun; 97(6):1881-3. PubMed ID: 22466333
    [No Abstract]   [Full Text] [Related]  

  • 6. Prenatal dexamethasone treatment in the context of at risk CAH pregnancies: Long-term behavioral and cognitive outcome.
    Karlsson L; Nordenström A; Hirvikoski T; Lajic S
    Psychoneuroendocrinology; 2018 May; 91():68-74. PubMed ID: 29529521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender role behaviour in prenatally dexamethasone-treated children at risk for congenital adrenal hyperplasia--a pilot study.
    Hirvikoski T; Lindholm T; Lajic S; Nordenström A
    Acta Paediatr; 2011 Sep; 100(9):e112-9. PubMed ID: 21388450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive outcome of offspring from dexamethasone-treated pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Meyer-Bahlburg HF; Dolezal C; Haggerty R; Silverman M; New MI
    Eur J Endocrinol; 2012 Jul; 167(1):103-10. PubMed ID: 22549088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-Dimorphic Effects of Prenatal Treatment With Dexamethasone.
    Wallensteen L; Zimmermann M; Thomsen Sandberg M; Gezelius A; Nordenström A; Hirvikoski T; Lajic S
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3838-3846. PubMed ID: 27482827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal dexamethasone treatment in pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: effect on midgestational amniotic fluid steroid levels.
    Dörr HG; Sippell WG
    J Clin Endocrinol Metab; 1993 Jan; 76(1):117-20. PubMed ID: 8421074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive and social function in girls with congenital adrenal hyperplasia -- influence of prenatally administered dexamethasone.
    Maryniak A; Ginalska-Malinowska M; Bielawska A; Ondruch A
    Child Neuropsychol; 2014; 20(1):60-70. PubMed ID: 23186079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies.
    New MI; Carlson A; Obeid J; Marshall I; Cabrera MS; Goseco A; Lin-Su K; Putnam AS; Wei JQ; Wilson RC
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5651-7. PubMed ID: 11739415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New management strategy of pregnancies at risk of congenital adrenal hyperplasia using fetal sex determination in maternal serum: French cohort of 258 cases (2002-2011).
    Tardy-Guidollet V; Menassa R; Costa JM; David M; Bouvattier-Morel C; Baumann C; Houang M; Lorenzini F; Philip N; Odent S; Guichet A; Morel Y
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1180-8. PubMed ID: 24471566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambulatory Blood Pressure Monitoring in Children and Adults Prenatally Exposed to Dexamethasone Treatment.
    Karlsson L; Wallensteen L; Nordenström A; Krmar RT; Lajic S
    J Clin Endocrinol Metab; 2022 May; 107(6):e2481-e2487. PubMed ID: 35148399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive and motor development of children with and without congenital adrenal hyperplasia after early-prenatal dexamethasone.
    Meyer-Bahlburg HF; Dolezal C; Baker SW; Carlson AD; Obeid JS; New MI
    J Clin Endocrinol Metab; 2004 Feb; 89(2):610-4. PubMed ID: 14764770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing female virilisation in congenital adrenal hyperplasia: The controversial role of antenatal dexamethasone.
    Heland S; Hewitt JK; McGillivray G; Walker SP
    Aust N Z J Obstet Gynaecol; 2016 Jun; 56(3):225-32. PubMed ID: 26661642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital adrenal hyperplasia: do the benefits of prenatal treatment defeat the risks?
    Vos AA; Bruinse HW
    Obstet Gynecol Surv; 2010 Mar; 65(3):196-205. PubMed ID: 20214835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of early prenatal dexamethasone on the cognitive and behavioral development of young children: results of a pilot study.
    Trautman PD; Meyer-Bahlburg HF; Postelnek J; New MI
    Psychoneuroendocrinology; 1995; 20(4):439-49. PubMed ID: 8532827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal diagnosis and treatment of 11beta-hydroxylase deficiency congenital adrenal hyperplasia resulting in normal female genitalia.
    Cerame BI; Newfield RS; Pascoe L; Curnow KM; Nimkarn S; Roe TF; New MI; Wilson RC
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3129-34. PubMed ID: 10487675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute encephalopathy with unilateral cortical-subcortical lesions in two unrelated kindreds treated with glucocorticoids prenatally for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: established facts and novel insight.
    Grunt S; Steinlin M; Weisstanner C; Schöning M; Mullis PE; Flück CE
    Horm Res Paediatr; 2013; 80(1):57-63. PubMed ID: 23816834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.